Specifically, B-ALL is classified into pro-B-ALL (CD10-), common-B ALL (CD10+), and pre-B-ALL (cytoplasmic IgM+), each with distinct characteristics. This evidence concerns the gene MME and acute lymphoblastic leukemia.